{
    "eid": "2-s2.0-85116014957",
    "title": "Optimization and validation of a novel three-dimensional co-culture system in decellularized human liver scaffold for the study of liver fibrosis and cancer",
    "cover-date": "2021-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "3D in vitro model",
        "Decellularized liver scaffolds",
        "Drug screening",
        "E-cadherin",
        "EMT",
        "Liver cancer",
        "Liver fibrosis",
        "Regorafenib",
        "SHP-1",
        "Sorafenib",
        "STAT3",
        "TGF\u03b21"
    ],
    "authors": [
        "Kessarin Thanapirom",
        "Elisabetta Caon",
        "Margarita Papatheodoridi",
        "Luca Frenguelli",
        "Walid Al-akkad",
        "Zhang Zhenzhen",
        "Maria Giovanna Vilia",
        "Massimo Pinzani",
        "Giuseppe Mazza",
        "Krista Rombouts"
    ],
    "citedby-count": 7,
    "ref-count": 64,
    "ref-list": [
        "Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma",
        "Three Dimensional Mixed-Cell Spheroids Mimic Stroma- Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma",
        "Electronic address, e.e.e.; European Association for the Study of the, L. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma",
        "Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma",
        "Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts",
        "Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents",
        "Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine",
        "Monocyte-endothelium-smooth muscle cell interaction in co-culture: Proliferation and cytokine productions in response to advanced glycation end products",
        "Engineering in vitro models of hepatofibrogenesis",
        "Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro",
        "Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis",
        "Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-beta1 Epithelial Mesenchy-mal Transition",
        "The niche of stellate cells within rat liver",
        "A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing",
        "3D in vitro models of liver fibrosis",
        "Three-dimensional cell culture: A powerful tool in tumor research and drug discovery",
        "Three-Dimensional Cell Cultures in Drug Discovery and Development",
        "Rapid production of human liver scaffolds for functional tissue engineering by high shear stress oscillation-decellularization",
        "Structural and functional hepatocyte polarity and liver disease",
        "Cells for bioartificial liver devices: The human hepatoma-derived cell line C3A produces urea but does not detoxify ammonia",
        "Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation",
        "Hep G2 is a hepatoblastoma-derived cell line",
        "Human hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis of hepatic fibrosis",
        "Activated stellate cells express the TRAIL receptor- 2/death receptor-5 and undergo TRAIL-mediated apoptosis",
        "Genetic characteristics of the human hepatic stellate cell line LX-2",
        "Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids",
        "Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): A randomised, double-blind, placebo-controlled, phase 3 trial",
        "Analyzing real-time PCR data by the comparative C(T) method",
        "The adenosine monophosphate-activated protein kinase-vacuolar adenosine triphosphatase-pH axis: A key regulator of the profibrogenic phenotype of human hepatic stellate cells",
        "Sorafenib in advanced hepatocellular carcinoma",
        "AASLD guidelines for the treatment of hepatocellular carcinoma",
        "Sorafenib: A potential therapeutic drug for hepatic fibrosis and its outcomes",
        "Sorafenib inhibition of hepatic stellate cell proliferation in tumor microenvironment of hepatocellular carcinoma: A study of the sorafenib mechanisms",
        "New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis",
        "Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis",
        "Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition",
        "Santamarine Inhibits NF-small ka, CyrillicB and STAT3 Activation and Induces Apoptosis in HepG2 Liver Cancer Cells via Oxidative Stress",
        "Regorafenib impairs mitochondrial functions, activates AMP-activated protein kinase, induces autophagy, and causes rat hepatocyte necrosis",
        "STAT3 aggravates TGF-beta1-induced hepatic epithelial-to-mesenchymal transition and migration",
        "SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma",
        "Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response",
        "AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro. American journal of physiology",
        "Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma",
        "P300 Acetyltrans-ferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells into Tumor-Promoting Myofibroblasts",
        "Transforming growth factor-beta as a therapeutic target in hepatocellular carcinoma",
        "TGF-beta in epithelial to mesenchymal transition and metastasis of liver carcinoma",
        "Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells",
        "Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis",
        "Serum fibronectin distinguishes the early stages of hepatocellular carcinoma",
        "Antifibrotic activity of sorafenib in experimental hepatic fibrosis: Refinement of inhibitory targets, dosing, and window of efficacy in vivo",
        "Beneficial effects of sorafenib on splanchnic, intrahe-patic, and portocollateral circulations in portal hypertensive and cirrhotic rats",
        "Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats",
        "STAT3 in hepatocellular carcinoma: New perspectives",
        "STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis",
        "3D spheroid cultures improve the metabolic gene expression profiles of HepaRG cells",
        "Three-dimensional Organotypic Culture Models of Human Hepatocellular Carcinoma",
        "A novel three-dimensional culture system maintaining the physiological extracellular matrix of fibrotic model livers ac-celerates progression of hepatocellular carcinoma cells",
        "Role of three-dimensional matrix stiffness in regulating the chemoresistance of hepatocellular carcinoma cells",
        "Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical anti-tumor activity",
        "Role of epithelial to mesenchymal transition in hepatocellular carcinoma",
        "Beyond TGFbeta: Roles of other TGFbeta superfamily members in cancer. Nature reviews",
        "Regorafenib (Stivarga) pharmaco-logically targets epithelial-mesenchymal transition in colorectal cancer",
        "STAT3 mediates regorafenib-induced apoptosis in hepatocellular carcinoma",
        "SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression"
    ],
    "affiliation": [
        {
            "affiliation-city": "London",
            "@id": "60032819",
            "affilname": "The Royal Free Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032819",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "London",
            "@id": "60022148",
            "affilname": "University College London",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022148",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "EASL Consortium for Regenerative Hepatology",
        "Fiorina Fund",
        "Royal Free Charity",
        "NHSBT",
        "NIHR UCL Biomedical Research Centre"
    ]
}